Popular Articles

A Selection Of Editorials And Opinions
The Slow, Slow Pulse Of The Deliberative Body The Washington Post
diet pills
Opinion Pieces Comment On Obama's Notre Dame Speech, Abortion Debate
Several newspapers recently published opinion pieces regarding President Obama"s commencement address at the University of Notre Dame. Summaries appear below.~ Cal Thomas, Washington Times: "Put aside the question of whether" Notre Dame should have invited President Obama to speak at its commencement ceremony on Sunday and "[f]ocus, instead, on [his] remarks and whether he is serious, or can be made so, about actually reducing the number of abortions in America," syndicated columnist Thomas writes in a Washington Times opinion piece. "Don"t put aside, however, the argument that there is only one reason to even want to reduce the number of abortions and that is that what is being killed, terminated, evacuated (choose your term) is, in fact, human life," Thomas adds. "In speaking of "original sin," the president hit upon why abortion has been so easily tolerated for so long," he writes, adding that Obama "spoke of "self-interest" and "crass materialism" but did so in the context of economics, not abortion." Thomas reports that Obama called for making adoption ""more available"" and providing ""care and support for women who do carry their children to term."" Thomas notes that Obama"s speech also included "an appeal for discussion and respect for people with different views," which was "a good beginning, but the ending is what counts, and the initial actions of this president when it comes to abortion and stem cell research have not been pro-life" (Thomas, Washington Times, 5/19).~ Tim Rutten, Los Angeles Times: After his commencement address at Notre Dame, "it"s now clear that the president is the rhetorical equivalent of a "money player,"" which is the "kind of competitor who steps up and delivers in the big games," Rutten writes in a Los Angeles Times opinion piece. Notre Dame"s invitation for Obama to speak at commencement and receive an honorary degree "bec[a]me an engine of controversy" because of protests from "reductionists," or conservative Catholics "who insist on bringing the broad sweep of Catholic social morality down to a single issue -- abortion," Rutten writes. However, Obama "negotiated the situation with remarkable ease," Rutten continues, adding that Obama was "speaking … to three audiences far from South Bend on Sunday." The first audience was the "crucial bloc of Catholic voters who seem to be looking for ways to remain in the Democratic Party," he writes. In addition, Obama was speaking to "those Catholic Democrats in public office ... who are under intense pressure from the reductionist bishops in their home dioceses" and to the U.S. Senate, which will likely ask Obama"s Supreme Court nominee about his or her views on abortion during confirmation hearings, Rutten continues. He concludes, "Even in Washington"s charged partisan atmosphere, it will be hard to ignore the president"s call for civility at Notre Dame" (Rutten, Los Angeles Times, 5/20).~ Clarence Page, Chicago Tribune: Obama "appropriately promoted" the "ability of adversaries to work together on mutual interests" in his commencement address, Page writes in a Tribune opinion piece. Page adds that the speech was "classic Obama the pragmatist: Look past ideology, try to ignore disagreements and work together on mutual interests." Obama said that "at some level, the views of the two camps are irreconcilable," Page writes, adding that it is "because Americans hold no values more dear than "life" and "choice."" Page adds that "[i]n the abortion debate, those values clash head-on." However, Obama"s "eloquent come-together oratory enabled him to leave the university like a hero, even though he glossed over the thorny specifics that drive wedges between people of goodwill when words are hammered into law," Page continues. "For now, by focusing on civility, the president apparently hopes to defuse the abortion powder keg long enough to address his higher priorities," Page writes, concluding, "The economy, national security and health care are going to be tough fight
News of the day
University Of Maryland Dental School Helps Doctors, Nurses Halt Infant Tooth Decay
Across the state of Maryland, there are now doctors and nurses, freshly trained in pediatric dental health care, who can help stem an alarming number of 3-year-old children who arrive for their first dentist visit with teeth "just melting away."
Endocrinology

FDA Approves Vaccine For 2009-2010 Seasonal Influenza

The U.S. Food and Drug Administration announced that it has approved a vaccine for 2009-2010 seasonal influenza in the United States. The seasonal influenza vaccine will not protect against the 2009 H1N1 influenza virus that resulted in the declaration of a pandemic by the World Health Organization (WHO) on June 11, 2009. The FDA continues to work with manufacturers, international partners and other government agencies to facilitate the availability of a safe and effective vaccine against the 2009 H1N1 influenza virus. Although this year"s seasonal vaccine is directed against other strains of influenza expected to be circulating and will not provide protection against the 2009 H1N1 influenza virus, it is still important for those Americans for whom it is recommended to receive the seasonal influenza vaccine. No vaccine is 100 percent effective against preventing disease, but vaccination is the best protection against influenza and can prevent many illnesses and deaths. "The approval of this year"s seasonal influenza vaccine is an example of the FDA"s important responsibility to assure timely availability of vaccine to help protect the health of the American public," said Margaret A. Hamburg, M.D., commissioner of food and drugs. "A new seasonal influenza vaccine each year is a critical tool in protecting public health." The six vaccine brand names and manufacturers are: Afluria, CSL Limited; Fluarix, GlaxoSmithKline Biologicals; FluLaval, ID Biomedical Corporation; Fluvirin, Novartis Vaccines and Diagnostics Limited; Fluzone, Sanofi Pasteur Inc.; and FluMist, MedImmune Vaccines Inc. Each year, experts from the FDA, WHO, U.S. Centers for Disease Control and Prevention (CDC), and other institutions study virus samples and patterns collected from around the world in an effort to identify strains that may cause the most illness in the upcoming season. Based on those forecasts and on the recommendations of the FDA"s Vaccine and Related Products Advisory Committee, the FDA determines the three strains that manufacturers should include in their vaccines for the U.S. population. The closer the match between the circulating strains and the strains in the vaccine, the better the protection against the disease. The vaccine for the 2009-2010 seasonal influenza contains: - an A/Brisbane/59/2007 (H1N1)-like virus - an A/Brisbane/10/2007 (H3N2)-like virus - a B/Brisbane/60/2008-like virus There is always a possibility of a less than optimal match between the virus strains predicted to circulate and the virus strains that end up causing the most illness. Even if the vaccine and the circulating strains are not an exact match, the vaccine may reduce the severity of the illness or may help prevent influenza-related complications. According to the CDC, between 5 percent and 20 percent of the U.S. population develops influenza each year. More than 200,000 are hospitalized from its complications and about 36,000 people die. Older people, young children, and people with chronic medical conditions are at higher risk for influenza-related complications. Vaccination of these groups is critical. Additionally, influenza immunization of health care personnel is important in protecting them and others from influenza. For more information: FDA Web Page on Influenza Vaccine Safety & Availability FDA List of Strains Included in the 2009-2010 Influenza Vaccine U.S. Centers for Disease Control and Prevention Web Page on Seasonal Influenza Res for Health Professionals U.S. Centers for Disease Control and Prevention Web Page with Key Fact About Seasonal Flu Vaccine U.S. Food and Drug Administration


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):